Skip to main content
Premium Trial:

Request an Annual Quote

454 Pays Celoxica $1.5M to Use Its Software In Neandertal Genome Project

NEW YORK (GenomeWeb News) – 454 Life Sciences has used software made by Celoxica Holdings to help it in its project to sequence the Neandertal genome, according to a British online news service.
Life Style Extra cited a Celoxica statement saying that 454 has “invested” $1.5 million in the company’s products, which it uses “to help accelerate the computing performance” of its sequencing technology.

According to LSE, the Celoxica RC2000 board provides the FPGA co-processing engine for the 454 sequencer, and that 454 uses Celoxica's DK Design Suite to program the algorithms in the FPGA.

Officials from 454 were not immediately available to confirm the report.
According to Celoxica's website, the company provides C-based design and behavioral synthesis tools. It provides electronic system level (ESL) co-design products that incorporate ANSI-C, Handel-C, and SystemC languages.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.